Enable Medicine Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
16
- Latest Deal Type
-
M&A
Enable Medicine General Information
Description
Developer of a bio-computational platform designed to extract valuable insights from various sample types. The company's platform includes custom panel development, data acquisition utilizing its imaging technology, and spatial data analysis, enabling guide researchers, drug developers, and physicians to generate cellular maps that assist in drug discovery.
Contact Information
Website
www.enablemedicine.com(Operating Subsidiary)
Corporate Office
- San Francisco, CA
- United States
Corporate Office
- San Francisco, CA
- United States
Enable Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 16-Dec-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 06-Apr-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 26-Aug-2020 | $3.62M | $3.62M | Completed | Generating Revenue |
Enable Medicine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 177,632 | $0.000100 | 6% | $1.46 | $1.46 | 1x | $1.46 | 1.37% |
| Seed-1 | 1,727,151 | $0.000100 | 6% | $1.83 | $1.83 | 1x | $1.83 | 13.28% |
Enable Medicine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Enable Medicine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Enable Medicine Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Anthos Capital | Venture Capital | Minority | ||
| Axial (San Francisco) | Venture Capital | Minority | ||
| Breyer Capital | Venture Capital | Minority | ||
| General Catalyst | Venture Capital | Minority | ||
| Inertia Ventures | Venture Capital | Minority |
Enable Medicine FAQs
-
When was Enable Medicine founded?
Enable Medicine was founded in 2019.
-
Where is Enable Medicine headquartered?
Enable Medicine is headquartered in San Francisco, CA.
-
What is the size of Enable Medicine?
Enable Medicine has 16 total employees.
-
What industry is Enable Medicine in?
Enable Medicine’s primary industry is Biotechnology.
-
Is Enable Medicine a private or public company?
Enable Medicine is a Private company.
-
What is Enable Medicine’s current revenue?
The current revenue for Enable Medicine is .
-
How much funding has Enable Medicine raised over time?
Enable Medicine has raised $63.6M.
-
Who are Enable Medicine’s investors?
Anthos Capital, Axial (San Francisco), Breyer Capital, General Catalyst, and Inertia Ventures are 5 of 7 investors who have invested in Enable Medicine.
-
When was Enable Medicine acquired?
Enable Medicine was acquired on 16-Dec-2024.
-
Who acquired Enable Medicine?
Enable Medicine was acquired by General Inception.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
